FDA Inspection
Teva Branded Pharmaceutical Products R&DTeva Branded Pharmaceutical Products R&D – FDA Inspection, May 19, 2010
Record Details
This FDA Inspection record concerns Teva Branded Pharmaceutical Products R&D, with an inspection on May 19, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 19, 2010
- Product Type
- Drugs
View Company Profile
ID · 37510991-d2e2-4d77-9dc5-7e9176e15aea
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 665436
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 314.80(b)Failure to review ADE information
- 21 CFR 314.81(b)(2)(i)Summary
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Teva Branded Pharmaceutical Products R&D
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 24, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 30, 2016 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 30, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 2, 2010 | NAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| July 31, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva Branded Pharmaceutical Products R&D
- FDA Inspection 1065622 - 2018-08-24
- FDA Inspection 981568 - 2016-06-30
- FDA Inspection 816199 - 2013-01-30
- FDA Inspection 703038 - 2010-12-02
- FDA Inspection 611034 - 2009-07-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.